Biotherapeutic and recombinant protein characterization
Our expertise in characterizing biotherapeutics and recombinant proteins
We offer comprehensive expertise in the characterization of biological macromolecules, from monoclonal antibodies (mAbs) to complex bioconjugates, glycoproteins and Antibody-Drug Conjugates (ADCs).
Our rigorous approach guarantees detailed analysis of your biomolecules to ensure their identity, purity, stability and efficacy throughout their development, from research to industrial production.
Using advanced technologies, we deliver reliable, reproducible results that meet the most stringent standards.
Which molecules ?
Our services also cover the characterization of emerging molecules such as peptides, oligonucleotides, bispecifics, nanobodies, as well as RNA-based products, including vaccines. By putting a wide range of analytical methods at your disposal, we help you to better understand the structure and functional properties of your biological products.
Whether you’re developing innovative treatments or optimizing existing products, our expertise is with you every step of the way.
Primary protein structure analysis (amino acids, peptide mapping) by HRMS (LC-Orbitrap)
Spectroscopic capabilities
Post-translational modification analysis (deamidation, oxidation, glycation, glycosylation, isomerization, Single Amino Acid Exchanges (SAAE), phosphorylation, scrambled disulfide bridges, truncation, N- and C-terminal modifications.)
Mass spectrometric methods (LC-Orbitrap, QTOF)
All recombinant protein analyses
